Thyroid and Endocrine Tumors Department, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
GRC No. 16, GRC Tumeurs Thyroïdiennes, Oncology Department, Pitié-Salpêtrière Hospital, Sorbonne Université, Paris, France.
Thyroid. 2022 Oct;32(10):1271-1276. doi: 10.1089/thy.2022.0136. Epub 2022 Sep 14.
Nuclear protein in testis (NUT) carcinomas (NC) are a rare, highly aggressive, subset of squamous cell carcinomas, characterized by a translocation involving the gene. Thyroid location of NUT carcinomas has rarely been described. We report here two cases of thyroid NC with translocation. The first case presented as a very aggressive undifferentiated thyroid carcinoma in a 38-year-old man who died 21 months after the diagnosis. The second case was diagnosed after multiple lymphadenopathy recurrences mainly in the neck in a 37-year-old woman 7 years after total thyroidectomy for papillary thyroid carcinoma with a classic and a solid/trabecular component. Our case reports highlight the challenges in diagnosing these exceptional carcinomas. The therapeutic impact of the administration of pharmacological compounds with epigenetic action, in line with the physiopathology of these carcinomas, is also discussed.
睾丸核蛋白(NUT)癌(NC)是一种罕见的、高度侵袭性的鳞状细胞癌亚群,其特征在于涉及 基因的易位。甲状腺 NUT 癌的位置很少被描述。我们在此报告两例甲状腺 NC 伴 易位。第一例病例是一名 38 岁男性,表现为非常侵袭性的未分化甲状腺癌,诊断后 21 个月死亡。第二例病例是在一名 37 岁女性中诊断出来的,该女性在 7 年前因经典型和实性/小梁型的甲状腺乳头状癌行全甲状腺切除术,此后出现主要发生在颈部的多个淋巴结病复发。我们的病例报告强调了诊断这些罕见癌的挑战。还讨论了根据这些癌的病理生理学,给予具有表观遗传作用的药理化合物的治疗效果。